Δ
Race Oncology Limited (ASX: RAC) is pleased to share the final results of our collaborative…
Bisantrene found to be more effective compared to doxorubicin and epirubicin in ovarian cancer cell…
Race enters a collaborative preclinical research program with The University of Newcastle to explore use…